FIELD: chemistry.
SUBSTANCE: described are compounds of formula I in form of free base or acid-additive salt, method of their obtaining, pharmaceutical composition based on them and their application s antagonists of metabotropic glutamate receptors (mGluR5). The invention can be applied in the treatment of the illnesses connected with the disorder of glutamatic signal transfer and the disorder of nervous system partially or completety mediate mGluR5. In general formula T represents 0 or 1, A represents hydroxy, X represents hydrogen, Y represents hydrogen or A forms simple bond with X or Y; ring methylene group directly bound with CH(X)-, can be dimethylated; R0 represents hydrogen, C1-C4alkyl, C1-C4alkoxy, halogen, cyano, and R represents -COR3, -COOR3 or -SO2R6,where R3 represents C1-C4alkyl, C3-C7cycloakyl, and R6 represents C1-C4alkyl, C3-C7cycloakyl, or R represents -C(O)R3, where R3 represents furanyl, trifluoromethyl, pyridinyl, morpholinyl or methylpiperasinyl; or -C(O)OR3, where R3 represents tetrahydrofuranyl, R' represents hydrogen, C1-C4alkyl or 4-methoxybenzyl, and R" represents hydrogen or C1-C4alkyl, or R' and R" together form group -CH2-(CH2)p-, where p represents 0, 1 or 2, one of symbols n and p does not represent 0, on condition that R0 does not represent hydrogen, trifluoromethyl and methoxy, when m represents 1, n represents 0, A represents hydroxy, X and Y both represent hydrogen, R represents COOEt and R' and R" together form group -(CH2)2-.
EFFECT: efficient application of compounds for treatment of diseases caused by disturbance of transduction of glutamatergic signal and diseases of nervous system.
8 cl, 11 ex
Title | Year | Author | Number |
---|---|---|---|
METABOTROPIC GLUTAMATE RECEPTOR MODULATORS FOR TREATING PARKINSON'S DISEASE | 2008 |
|
RU2508107C2 |
COMBINATIONS CONTAINING mGluR MODULATORS FOR TREATING PARKINSON'S DISEASE | 2009 |
|
RU2496494C2 |
APPLICATION OF ANTAGONISTS OF METABOTROPIC GLUTAMATE RECEPTORS (mGLuR5), ESPECIALLY AFQ056, FOR TREATMENT OF GASTROINTESTINAL TRACT (GIT), ESPECIALLY GASTROESOPHAGEAL REFLUX (GER) | 2006 |
|
RU2422138C2 |
ARYLETHINYL DERIVATIVES | 2011 |
|
RU2573560C2 |
PHENYLETHENYL- OR PHENYLETHYNYL-DERIVATIVES AS ANTAGONISTS OF GLUTAMATE RECEPTORS | 2001 |
|
RU2284323C9 |
TETRAHYDROPYRANE DERIVATIVES FOR NEUROLOGICAL DISEASES | 2011 |
|
RU2554344C2 |
DERIVATIVES OF PERHYDROISOINDOLE, METHODS OF THEIR SYNTHESIS, A PHARMACEUTICAL COMPOSITION BASED ON SAID | 1993 |
|
RU2127260C1 |
ANTAGONISTS OF ENDOTHELIAL RECEPTORS, PHARMACEUTICAL COMPOSITION, METHOD OF SYNTHESIS, METHOD OF INHIBITION OF ENDOTHELIAL RECEPTORS | 1992 |
|
RU2125980C1 |
PERHYDROISOINDOLE DERIVATIVES AND METHOD OF PREPARATION THEREOF | 1993 |
|
RU2120438C1 |
METHOD OF PRODUCING LACTONES | 0 |
|
SU749364A3 |
Authors
Dates
2008-12-20—Published
2002-12-03—Filed